ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,557Medicare Part D Prescriptions Filled, Including Refills

Rank: 478 out of 3734

$423K Total Retail Price of All Prescriptions

Rank: 977 out of 3734

435 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 4,866 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
PRAVASTATIN SODIUM 597 236 1 15
QUINAPRIL HCL 515 288 10 2 74
OMEPRAZOLE 492 179 3 4
AMLODIPINE BESYLATE 444 309 4 5
HYDROCHLOROTHIAZIDE 412 169 5 9
FUROSEMIDE 282 118 6 7
LEVOTHYROXINE SODIUM 274 148 7 2
LISINOPRIL 267 149 8 3
FENOFIBRATE 263 74 9 81
POTASSIUM CHLORIDE 236 98 10 19
METFORMIN HCL 234 85 11 8
GLIPIZIDE XL 217 134 12 85
DICLOFENAC SODIUM 209 66 13 127
VENTOLIN HFA 175 67 14 70
METOPROLOL TARTRATE 174 77 15 6
TRAMADOL HCL 164 77 16 20
SIMVASTATIN 155 88 17 1
GLIMEPIRIDE 149 41 18 37
GABAPENTIN 148 61 19 17
TRAZODONE HCL 132 48 20 49
NIFEDIPINE ER 132 80 20 113
SERTRALINE HCL 131 36 22 18
ALENDRONATE SODIUM 127 47 23 26
LANTUS 115 50 24 54
IBUPROFEN 105 42 25 75
METOPROLOL SUCCINATE 101 83 26 14
ATENOLOL 100 55 27 13
OXYBUTYNIN CHLORIDE ER 97 41 28 141
ADVAIR DISKUS 93 73 29 35
ATORVASTATIN CALCIUM 92 60 30 11
FLUTICASONE PROPIONATE 90 19 31 46
FLOVENT HFA 86 11 32 199
PROAIR HFA 86 52 32 83
SINGULAIR 84 45 34 95
KLOR-CON M10 78 29 35 115
HUMALOG 77 33 36 146
OXYBUTYNIN CHLORIDE 72 26 37 151
AMITRIPTYLINE HCL 69 19 R 38 94
INSULIN SYRINGE 65 30 39 109
HYDROCODONE-ACETAMINOPHEN 65 28 S3 39 12
CLOPIDOGREL 64 46 41 23
GLIPIZIDE 64 22 41 57
RANITIDINE HCL 61 15 43 32
DOXAZOSIN MESYLATE 60 26 44 100
CLONIDINE HCL 60 32 44 79
NAPROXEN 59 35 46 101
AMOXICILLIN 58 21 47 108
LANTUS SOLOSTAR 55 0 48 102
ENALAPRIL MALEATE 54 0 49 63
CITALOPRAM HBR 52 20 50 16
SPIRIVA 51 51 51 40
TRICOR 50 25 52 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.